Microfluidics Market Accelerates Toward USD 130.7 Billion by 2035
According to Shivani Zoting, who specializes in medical devices, life sciences, and healthcare technology markets, with 5+ years of experience in market research and industry analysis, the microfluidics market is set for sustained double-digit growth, driven by rising adoption of point-of-care diagnostics, lab-on-a-chip technologies, and expanding biomedical applications. Her analysis shows the market is expected to grow from USD 45.28 billion in 2026 to USD 130.70 billion by 2035, with the medical/healthcare, PDMS, and lab-on-a-chip segments leading demand. She identifies North America as the current market leader, while Asia Pacific is emerging as the fastest-growing region, supported by increasing R&D investments and healthcare innovation. The competitive landscape remains strong, with companies including Abbott, Thermo Fisher Scientific, Danaher Corporation, Illumina, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Standard BioTools, Takara Bio, RedShiftBio, and F. Hoffmann-La Roche driving technological advancements and market expansion.
Last Updated : 10 July 2026
Category: Diagnostics
Insight Code: 5186
Format: PDF / PPT / Excel